Lineage Cell Stock Forecast - Naive Prediction

LCTX Stock  USD 1.76  0.06  3.53%   
The Naive Prediction forecasted value of Lineage Cell Therapeutics on the next trading day is expected to be 1.68 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.13. Lineage Stock Forecast is based on your current time horizon.
At this time the rsi of Lineage Cell's share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Lineage Cell's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Lineage Cell Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Lineage Cell's stock price prediction:
EPS Estimate Next Quarter
(0.03)
EPS Estimate Current Year
(0.29)
EPS Estimate Next Year
(0.06)
Wall Street Target Price
4.1667
Quarterly Revenue Growth
(0.03)
Using Lineage Cell hype-based prediction, you can estimate the value of Lineage Cell Therapeutics from the perspective of Lineage Cell response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Lineage Cell using Lineage Cell's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Lineage using crowd psychology based on the activity and movement of Lineage Cell's stock price.

Lineage Cell Implied Volatility

    
  1.49  
Lineage Cell's implied volatility exposes the market's sentiment of Lineage Cell Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Lineage Cell's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Lineage Cell stock will not fluctuate a lot when Lineage Cell's options are near their expiration.
The Naive Prediction forecasted value of Lineage Cell Therapeutics on the next trading day is expected to be 1.68 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.13.

Lineage Cell after-hype prediction price

    
  USD 1.96  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Lineage Cell to cross-verify your projections.
At this time, Lineage Cell's Inventory Turnover is fairly stable compared to the past year. Receivables Turnover is likely to rise to 16.30 in 2026, whereas Payables Turnover is likely to drop 0.17 in 2026. . Common Stock Shares Outstanding is likely to rise to about 241.7 M in 2026, whereas Net Loss is likely to drop (31.7 M) in 2026.

Open Interest Against 2026-03-20 Lineage Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Lineage Cell's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Lineage Cell's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Lineage Cell stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Lineage Cell's open interest, investors have to compare it to Lineage Cell's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Lineage Cell is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Lineage. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Lineage Cell Additional Predictive Modules

Most predictive techniques to examine Lineage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lineage using various technical indicators. When you analyze Lineage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Lineage Cell's financial statements to predict how it will affect future prices.
 
Cash  
First Reported
1992-03-31
Previous Quarter
42.3 M
Current Value
40.5 M
Quarterly Volatility
16.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Lineage Cell is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Lineage Cell Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Lineage Cell Naive Prediction Price Forecast For the 9th of January

Given 90 days horizon, the Naive Prediction forecasted value of Lineage Cell Therapeutics on the next trading day is expected to be 1.68 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 3.13.
Please note that although there have been many attempts to predict Lineage Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lineage Cell's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Lineage Cell Stock Forecast Pattern

Backtest Lineage CellLineage Cell Price PredictionBuy or Sell Advice 

Lineage Cell Forecasted Value

In the context of forecasting Lineage Cell's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Lineage Cell's downside and upside margins for the forecasting period are 0.02 and 5.19, respectively. We have considered Lineage Cell's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.76
1.68
Expected Value
5.19
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Lineage Cell stock data series using in forecasting. Note that when a statistical model is used to represent Lineage Cell stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.6229
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0514
MAPEMean absolute percentage error0.0295
SAESum of the absolute errors3.1326
This model is not at all useful as a medium-long range forecasting tool of Lineage Cell Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Lineage Cell. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Lineage Cell

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lineage Cell Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lineage Cell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.101.965.47
Details
Intrinsic
Valuation
LowRealHigh
0.112.275.78
Details
7 Analysts
Consensus
LowTargetHigh
3.794.174.63
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.03-0.020.00
Details

Other Forecasting Options for Lineage Cell

For every potential investor in Lineage, whether a beginner or expert, Lineage Cell's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lineage Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lineage. Basic forecasting techniques help filter out the noise by identifying Lineage Cell's price trends.

Lineage Cell Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lineage Cell stock to make a market-neutral strategy. Peer analysis of Lineage Cell could also be used in its relative valuation, which is a method of valuing Lineage Cell by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Lineage Cell Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Lineage Cell's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Lineage Cell's current price.

Lineage Cell Market Strength Events

Market strength indicators help investors to evaluate how Lineage Cell stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lineage Cell shares will generate the highest return on investment. By undertsting and applying Lineage Cell stock market strength indicators, traders can identify Lineage Cell Therapeutics entry and exit signals to maximize returns.

Lineage Cell Risk Indicators

The analysis of Lineage Cell's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lineage Cell's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lineage stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lineage Stock Analysis

When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.